Physician

Elizabeth Kate Blixt, MD

According to 2025 Medicare claims, Elizabeth Blixt, MD (NPI: 1487900577) practices dermatology in the St. Cloud, MN market, with the plurality of this provider's patient population coming from Stearns, MN. This provider's primary affiliated billing organization is CENTRACARE CLINIC (NPI: 1407858020; TIN: 411806657) and primary practice location at 56303-1116. Blixt is affiliated with the Central Minnesota ACO, LLC (ACO ID: A2844), participating under the MSSP model.

Blixt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 554 traditional Medicare patients, billed 3,136 HCPCS/CPT codes, and received $177,449 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,267 prescription claims across 395 beneficiaries totaling $1,255,879 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $43,392 to $177,449. Similarly, Part D prescription costs have risen steadily, from $30,279 to $1,255,879. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$93K$187K2015 Medicare payment: $43,392 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $25,930 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $43,437 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $78,093 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $167,398 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $126,931 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $186,355 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $157,519 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $186,704 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $177,449 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153861,211$43,392
2016264722$25,930
20171801,009$43,437
20182501,404$78,093
20194802,389$167,398
20204652,026$126,931
20215282,707$186,355
20225632,251$157,519
20235262,439$186,704
20245543,136$177,449

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$628K$1.3M2015 Drug cost: $30,279 (USD; Tot_Drug_Cst)2016 Drug cost: $46,762 (USD; Tot_Drug_Cst)2017 Drug cost: $129,745 (USD; Tot_Drug_Cst)2018 Drug cost: $176,862 (USD; Tot_Drug_Cst)2019 Drug cost: $432,889 (USD; Tot_Drug_Cst)2020 Drug cost: $720,987 (USD; Tot_Drug_Cst)2021 Drug cost: $1,062,636 (USD; Tot_Drug_Cst)2022 Drug cost: $983,390 (USD; Tot_Drug_Cst)2023 Drug cost: $882,472 (USD; Tot_Drug_Cst)2024 Drug cost: $1,255,879 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015128287$30,279
2016165399$46,762
2017177475$129,745
2018229665$176,862
2019266863$432,889
20203081,039$720,987
20213461,162$1,062,636
20223671,154$983,390
20233721,117$882,472
20243951,267$1,255,879

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more142187$77
11102Biopsy of related skin growth, first growth101111$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more356405$56
17000Destruction of precancer skin growth, 1 growth175208$37
17003Destruction of precancer skin growth, 2-14 growths115460$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa11924$217,207
Taltz AutoinjectorIxekizumab23644$148,303
Cosentyx Unoready PenSecukinumab15420$129,725
Dupixent PenDupilumab27728$101,618
Enbrel SureclickEtanercept13364$97,497

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Elizabeth Kate Blixt, MD?

Tedicare shows public-source Medicare data for Elizabeth Kate Blixt, MD (NPI 1487900577), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elizabeth Kate Blixt, MD have ACO affiliation data?

Elizabeth Kate Blixt, MD is shown with ACO affiliation data for Central Minnesota ACO, LLC (MSSP, ACO ID A2844).

What billing organization is linked to Elizabeth Kate Blixt, MD?

Elizabeth Kate Blixt, MD is linked to CENTRACARE CLINIC (billing NPI 1407858020) in the available physician profile data.

Does Elizabeth Kate Blixt, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.